A proactive approach to cardiac care
We are building the first non-invasive monitoring platform to give early warning of declining heart function and provide insights to inform optimal therapy in any setting.
Caution: Investigational Device.
Limited by Federal (or United States) Law to Investigational Use.
Non-invasive monitoring
There are clear physiological changes preceding acute cardiac events, but detection has traditionally required invasive catheters and implants.
Cardiosense is developing a platform combining biosensors and AI to enable hemodynamic monitoring wherever a patient goes.
Actionable insights
Cardiosense monitoring and analytics can detect early signs of cardiac decline before any symptoms appear.
This will allow care teams to prioritize at-risk patients, implement proactive therapeutic interventions, and monitor recovery.
sensor-fusion approach
We leverage a novel combination of sensors to capture
the full electromechnical behavior of every heartbeat.
Team
Amit Gupta, MBA
CEO
Andrew Carek, PhD
CTO
Avi Kazen, MS
VP Engineering
Patrick Hunt, MBA
VP Marketing & Strategy
Luke Neill, MD
VP, Clinical Affairs
Alex Heller, MS
Hardware Lead
Liviu klein, md
Clinical Advisor
Omer Inan, PHD
Scientific Advisor
Scott Greenberg
Strategic Advisor
Mozziyar Etemadi, MD, PhD
Scientific Advisor